Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease.
Open Access
- 1 August 1978
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 41 (8) , 709-712
- https://doi.org/10.1136/jnnp.41.8.709
Abstract
In a study of oesophageal motility in 20 patients with Parkinson's disease, intravenous atropine produced marked disruption of co-ordination in response to swallows, when compared with control subjects. This suggests that cholinergic rather than dopaminergic mechanisms are more important in the control of swallowing in patients with Parkinsonism. No conclusive evidence of peripheral dopamine depletion or autonomic neuropathy was found, although minor changes suggestive of the former were found in severely affected patients.This publication has 19 references indexed in Scilit:
- DOPAMINE ACETYLCHOLINE IMBALANCE IN PARKINSON'S DISEASEThe Lancet, 1976
- Pharmacology of the Esophageal Motor FunctionAnnual Review of Pharmacology, 1975
- Neural Control of the Lower Esophageal Sphincter INFLUENCE OF THE VAGUS NERVESJournal of Clinical Investigation, 1974
- Oesophageal dilatation in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1974
- ORTHOSTATIC HYPOTENSION IN PARKINSON'S DISEASEThe Lancet, 1972
- ROLE OF THE PONTINE RETICULAR FORMATION IN THE NEURAL ORGANIZATION OF DEGLUTITIONThe Japanese Journal of Physiology, 1972
- Autonomic Deficits in Parkinson's SyndromeArchives of Neurology, 1971
- Esophageal responses to distension and electrical stimulationJournal of Clinical Investigation, 1969
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967
- Segmental spasms of the esophagus and their relation to ParkinsonismDigestive Diseases and Sciences, 1942